お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は母乳オリゴ糖（HMO）市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは母乳オリゴ糖（HMO）の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の母乳オリゴ糖（HMO）市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは母乳オリゴ糖（HMO）のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に母乳オリゴ糖（HMO）市場を分類しています。本研究に含まれる主な企業は：Abbott、Inbiose、Glycom、Chr. Hansen (Jennewein)、Elicityl SA、ZuChem

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    2'-FL & 3-FL
    LNT & LNnT, etc.

用途別の市場セグメント：
    Infant Formula
    Others

本レポートの詳細内容
世界の母乳オリゴ糖（HMO）市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、母乳オリゴ糖（HMO）タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の母乳オリゴ糖（HMO）収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の母乳オリゴ糖（HMO）市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、母乳オリゴ糖（HMO）市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

母乳オリゴ糖（HMO）のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：母乳オリゴ糖（HMO）のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：母乳オリゴ糖（HMO）の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章母乳オリゴ糖（HMO）企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：母乳オリゴ糖（HMO）の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：母乳オリゴ糖（HMO）の主要企業の概要を提供し、製品の説明と仕様、母乳オリゴ糖（HMO）の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

The global Human Milk Oligosaccharides (HMO) market is projected to grow from US$ 708 million in 2024 to US$ 2642 million by 2030, at a Compound Annual Growth Rate (CAGR) of 24.6% during the forecast period.
The core manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, DSM (Glycom) and Chr. Hansen (Jennewein). The top three companies hold about 83% of the market. North America is the world's largest Human Milk Oligosaccharides (HMO) market with a market share of about 54%, followed by Europe and Asia Pacific with a market share of 31% and 13%, respectively. In terms of product type, 2'-FL & 3-FL is the largest segments, accounting for approximately 96% of the market share. In terms of application, Infant Formula is the largest downstream sector, accounting for about 96% of the market share.
Report Includes
This report presents an overview of global market for Human Milk Oligosaccharides (HMO) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Human Milk Oligosaccharides (HMO), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Human Milk Oligosaccharides (HMO), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Human Milk Oligosaccharides (HMO) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Human Milk Oligosaccharides (HMO) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Human Milk Oligosaccharides (HMO) revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), Elicityl SA, ZuChem, etc.
Market Segmentation
By Company
    Abbott
    Inbiose
    Glycom
    Chr. Hansen (Jennewein)
    Elicityl SA
    ZuChem

Segment by Type
    2'-FL & 3-FL
    LNT & LNnT, etc.

Segment by Application
    Infant Formula
    Others

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Human Milk Oligosaccharides (HMO) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Milk Oligosaccharides (HMO) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Milk Oligosaccharides (HMO) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of 2'-FL & 3-FL
 Table 3. Key Players of LNT & LNnT, etc.
 Table 4. Global Human Milk Oligosaccharides (HMO) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Human Milk Oligosaccharides (HMO) Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Human Milk Oligosaccharides (HMO) Market Share by Region (2019-2024)
 Table 8. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Human Milk Oligosaccharides (HMO) Market Share by Region (2025-2030)
 Table 10. Human Milk Oligosaccharides (HMO) Market Trends
 Table 11. Human Milk Oligosaccharides (HMO) Market Drivers
 Table 12. Human Milk Oligosaccharides (HMO) Market Challenges
 Table 13. Human Milk Oligosaccharides (HMO) Market Restraints
 Table 14. Global Human Milk Oligosaccharides (HMO) Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Human Milk Oligosaccharides (HMO) Market Share by Players (2019-2024)
 Table 16. Global Top Human Milk Oligosaccharides (HMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2023)
 Table 17. Global Human Milk Oligosaccharides (HMO) Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Human Milk Oligosaccharides (HMO) Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Human Milk Oligosaccharides (HMO), Headquarters and Area Served
 Table 20. Global Key Players of Human Milk Oligosaccharides (HMO), Product and Application
 Table 21. Global Key Players of Human Milk Oligosaccharides (HMO), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2019-2024)
 Table 25. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2025-2030)
 Table 27. Global Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2019-2024)
 Table 29. Global Human Milk Oligosaccharides (HMO) Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2025-2030)
 Table 31. North America Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Human Milk Oligosaccharides (HMO) Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Human Milk Oligosaccharides (HMO) Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Human Milk Oligosaccharides (HMO) Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Human Milk Oligosaccharides (HMO) Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Human Milk Oligosaccharides (HMO) Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Human Milk Oligosaccharides (HMO) Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Human Milk Oligosaccharides (HMO) Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Human Milk Oligosaccharides (HMO) Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Human Milk Oligosaccharides (HMO) Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Human Milk Oligosaccharides (HMO) Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Human Milk Oligosaccharides (HMO) Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Human Milk Oligosaccharides (HMO) Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Abbott Company Details
 Table 64. Abbott Business Overview
 Table 65. Abbott Human Milk Oligosaccharides (HMO) Product
 Table 66. Abbott Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 67. Abbott Recent Development
 Table 68. Inbiose Company Details
 Table 69. Inbiose Business Overview
 Table 70. Inbiose Human Milk Oligosaccharides (HMO) Product
 Table 71. Inbiose Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 72. Inbiose Recent Development
 Table 73. Glycom Company Details
 Table 74. Glycom Business Overview
 Table 75. Glycom Human Milk Oligosaccharides (HMO) Product
 Table 76. Glycom Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 77. Glycom Recent Development
 Table 78. Chr. Hansen (Jennewein) Company Details
 Table 79. Chr. Hansen (Jennewein) Business Overview
 Table 80. Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product
 Table 81. Chr. Hansen (Jennewein) Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 82. Chr. Hansen (Jennewein) Recent Development
 Table 83. Elicityl SA Company Details
 Table 84. Elicityl SA Business Overview
 Table 85. Elicityl SA Human Milk Oligosaccharides (HMO) Product
 Table 86. Elicityl SA Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 87. Elicityl SA Recent Development
 Table 88. ZuChem Company Details
 Table 89. ZuChem Business Overview
 Table 90. ZuChem Human Milk Oligosaccharides (HMO) Product
 Table 91. ZuChem Revenue in Human Milk Oligosaccharides (HMO) Business (2019-2024) & (US$ Million)
 Table 92. ZuChem Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Human Milk Oligosaccharides (HMO) Market Share by Type: 2023 VS 2030
 Figure 3. 2'-FL & 3-FL Features
 Figure 4. LNT & LNnT, etc. Features
 Figure 5. Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Human Milk Oligosaccharides (HMO) Market Share by Application: 2023 VS 2030
 Figure 7. Infant Formula Case Studies
 Figure 8. Others Case Studies
 Figure 9. Human Milk Oligosaccharides (HMO) Report Years Considered
 Figure 10. Global Human Milk Oligosaccharides (HMO) Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 11. Global Human Milk Oligosaccharides (HMO) Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Human Milk Oligosaccharides (HMO) Market Share by Region: 2023 VS 2030
 Figure 13. Global Human Milk Oligosaccharides (HMO) Market Share by Players in 2023
 Figure 14. Global Top Human Milk Oligosaccharides (HMO) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2023)
 Figure 15. The Top 10 and 5 Players Market Share by Human Milk Oligosaccharides (HMO) Revenue in 2023
 Figure 16. North America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 17. North America Human Milk Oligosaccharides (HMO) Market Share by Type (2019-2030)
 Figure 18. North America Human Milk Oligosaccharides (HMO) Market Share by Application (2019-2030)
 Figure 19. North America Human Milk Oligosaccharides (HMO) Market Share by Country (2019-2030)
 Figure 20. United States Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Canada Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Human Milk Oligosaccharides (HMO) Market Share by Type (2019-2030)
 Figure 24. Europe Human Milk Oligosaccharides (HMO) Market Share by Application (2019-2030)
 Figure 25. Europe Human Milk Oligosaccharides (HMO) Market Share by Country (2019-2030)
 Figure 26. Germany Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. China Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Human Milk Oligosaccharides (HMO) Market Share by Type (2019-2030)
 Figure 34. China Human Milk Oligosaccharides (HMO) Market Share by Application (2019-2030)
 Figure 35. Asia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Asia Human Milk Oligosaccharides (HMO) Market Share by Type (2019-2030)
 Figure 37. Asia Human Milk Oligosaccharides (HMO) Market Share by Application (2019-2030)
 Figure 38. Asia Human Milk Oligosaccharides (HMO) Market Share by Region (2019-2030)
 Figure 39. Japan Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. South Korea Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. India Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Australia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Type (2019-2030)
 Figure 47. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Application (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Human Milk Oligosaccharides (HMO) Market Share by Country (2019-2030)
 Figure 49. Brazil Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Mexico Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Turkey Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Israel Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. GCC Countries Human Milk Oligosaccharides (HMO) Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. Abbott Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 56. Inbiose Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 57. Glycom Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 58. Chr. Hansen (Jennewein) Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 59. Elicityl SA Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 60. ZuChem Revenue Growth Rate in Human Milk Oligosaccharides (HMO) Business (2019-2024)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed